Solara Active Pharma Sciences Ltd.NSE: SOLARA

Press Release Jul 02 2021

· Issued by Solara Active Pharma Sciences Ltd.

Filed with NSE ·

Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated July 02, 2021, titled "Restoration of CEP for Ranitidine Hydrochloride Drug Substance granted by EDQM.".

View Attachment

6ix hasn’t read this filing yet.

Solara Active Pharma Sciences Ltd. on 6ix

Earlier from Solara Active Pharma Sciences

Later from Solara Active Pharma Sciences

All Solara Active Pharma Sciences news releases